
|Articles|October 15, 2003
Spreading agent approval sought for hyaluronidase
Irvine, CA-ISTA Pharmaceuticals is seeking FDA approval to use hyaluronidase (Vitrase) as a spreading agent to facilitate the dispersion and absorption of other drugs.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Retina experts reflect on how OCT transformed patient care
2
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
3
AAO 2025: 12-month outcomes of travoprost intracameral implant (iDose TR) in conjunction with cataract surgery
4
AAO 2025: The ASPIRE phase 2B trial of UBX1325 head-to-head against aflibercept
5



















































.png)


